Search Results For :: healthcare crm
-
North American Home Healthcare Market By Product [Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit], Services [Respiratory Therapy, Rehabilitation Therapy] & Telehealth - Forecasts To 2017
The North America home health care market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. Home healthcare market includes products, services, and telehealth. The home care product category comprises homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, fitness, and nutrition products. Services include unskilled care, rehabilitation therapy, infusion therapy, and respiratory therapy, while telehealth includes home telehealth monitoring devices and telehealth services.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
World Healthcare IT (Provider and Payor) Market - Clinical (EMR, PACS, RIS, CPOE, LIS) & Non-Clinical (RCM, Billing, Claims) Information systems Trends, opportunities & Forecast till 2015
The world healthcare IT market is expected to grow from $99.6 billion in 2010 to $162.2 billion in 2015, at a CAGR of 10.2% from 2010 to 2015. Need to cut healthcare costs, enhance clinical/administrative workflow of hospitals, and huge demand for faster, error-free, efficient healthcare delivery, is fueling the healthcare provider IT market worldwide. Furthermore, the initiatives taken by the government for adoption of healthcare IT systems globally are also a significant driving force. Some of the major initiatives expected to hugely impact the market are the U.S Healthcare reforms and ARRA incentives.
- Published: August 2011
- Price: $ 4950
- TOC Available:
-
Pharma & Healthcare Social Media Marketing Strategies –
Increasing number of web users’ world wide (1.8 billion), development and popularity of web based community sites (Twitter, Facebook), tools and information centers (branded & unbranded sponsored communities) are changing approach towards Pharma and healthcare marketing and information sharing. In pharma industry social media has emerged as an effective tool for marketing, consumer engagement, monitoring & analyzing user generated content and building & changing brand perception. Social media is emerging as a strategic shift in organizations communication and operation model. Top pharmaceutical market players have started integrating social media in to their marketing mix. The effective social media marketing strategies that can help generate business exposure, market research data, relationship building and thus can prove as an important initiative to boom sales and overall business in the long term
- Published: August 2010
- Price: $ 4950
- TOC Available:
-
Obama’s Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets – (Pharmaceuticals, Medical devices and Health insurance)
The US healthcare system ranks 37 among health care systems of about 200 worldwide countries ranked by World Health Organization. US health care system is considered as one of the most expensive healthcare system in the world, spending about 16% of its GDP on healthcare. However the rising healthcare costs and increasing health premiums rates along with high number of uninsured people (about 47 million i.e. 16% of the total population) are among the significant factors contributing to the need of health reform in the US. Health reform in the US is looked upon as an initiative towards provision of qualitative and affordable health coverage for all Americans, decrease in rising burden of healthcare costs and improvement in quality & efficiency of health care. Obama has signed health reform in to law, recently in March 2010, to improve the inefficiencies of the existing health care structure. The health reform bill outlays several provisions such as universal health coverage, cost containment, increase in insurance market competition, excise tax on medical device manufacturers and lower drug costs for Medicaid and Medicare are few to mention. Thus the provisions in the health reform directly and indirectly impact the US healthcare/pharmaceutical industry and its stakeholders.
- Published: August 2010
- Price: $ 4950
- TOC Available:
-
Home Healthcare Market By Equipment (Oxygen delivery systems, CPAP, nebulizers, ventilators, IV diagnostics, home dialysis, insulin delivery devices, and other equipment)
In this report, we have analyzed how the home healthcare market is evolving. The increasing population above the age group of 65 years covers about 70% of the entire market, while the elderly support population (population between 20-64 years of age) is declining. The lack of family members to support and care for the elderly at home generates a high demand for home care products and services. Along with this, the increased cost of hospital care services presents the largest opportunity for this market. Thus, many companies are eagerly approaching this segment with several customized products and services.
- Published: February 2010
- Price: $ 4950
- TOC Available:
-
Medical Membranes Market by Material (PSU, PES, PVDF, PTFE, PP, PAN, PA, Modified Acrylics), Process Technology (Ultrafiltration, Microfiltration, Nanofiltration), Application (Pharmaceutical Filtration, Hemodialysis, IV Fusion & Sterile Filtration, Membrane Oxygenator), and Region - Global Forecast to 2030
The medical membranes market is expected to grow from USD 4.31 billion in 2025 to USD 6.66 billion by 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period. The Key Players Asahi Kasei Corporation (Japan), Mann+Hummel (Germany), Sartorius AG (Germany), Merck KGaA (Germany), Solventum (US), Cytiva (US), W. L. Gore & Associates, Inc. (US), Kovalus Separation Solutions (US), and Cobetter (China).
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Biochips Market by Products & Services (Instruments, Software), Type (DNA Chips, Protein Chips, Lab-on-a-Chip), Application (High-throughput Screening, IVD, POC), Fabrication Technology (Microarrays, Microfluidics), & Region - Global Forecast to 2030
The global biochips market, valued at US$12,907.5 million in 2024, stood at US$14,011.6 million in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2024 to 2030, culminating in a forecasted valuation of US$21,356.4 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Immunoassay, NGS, PCR, Microscopy), Application (Diagnostic, Clinical), End User (Pharma, Agriculture & Food Industry, Hospital, Diagnostic Lab) - Global Forecasts to 2031
The global Life Science Instrumentation market, valued at US$59.9 billion in 2024, stood at US$63.4 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2030, culminating in a forecasted valuation of US$92.5 billion by the end of the period. The main drivers of the life science instrumentation market include increasing demand for advanced analytical technologies in drug discovery, genomics, and proteomics research, along with rising investments in pharmaceutical and biotechnology R&D.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Medical Sensors Market Size, by Sensor Type (Biopotential, Biophysical, Image), Product Type (Ingestible, External), Device Classification, Application, Connectivity, Technology, End User, & Region - Global Forecast to 2030
The global medical sensors market, valued at US$2.82 billion in 2024, stood at US$ 3.06 billion in 2025 and is projected to advance at a resilient CAGR of 7.9% from 2025 to 2030, culminating in a forecasted valuation of US$4.48 billion by the end of the period. This growth is mainly driven by the rising demand for connected healthcare solutions, the increasing prevalence of chronic diseases, and the broader adoption of wearable and minimally invasive medical devices in both hospital and home care settings.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Healthcare BPO Market by Size, Share, Trends by Outsourcing Models, Life Science (R&D, Manufacturing, Supply Chain, Sales & Marketing (Analytics)), Provider (Patient Care, RCM), Payer (Claims Management, Billing & Accounts), Region - Global Forecast to 2030
The global healthcare BPO market, valued at US$337.6 billion in 2024, stood at US$417.7 billion in 2025 and is projected to advance at a resilient CAGR of 10.7% from 2025 to 2030, culminating in a forecasted valuation of US$694.3 billion by the end of the period. Factors such as the increasing pressure to control rising healthcare costs, the transition to ICD-10 coding standards, the anticipated adoption of ICD-11, and the growing trend of outsourcing in the pharmaceutical and biopharmaceutical sectors are expected to drive market expansion during the forecast period.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 64
